- Home
- ACCO vs ARCT Comparison
ACCO vs ARCT Comparison
Compare ACCO & ARCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACCO
- ARCT
- Stock Information
- Founded
- ACCO 1893
- ARCT 2013
- Country
- ACCO United States
- ARCT United States
- Employees
- ACCO N/A
- ARCT N/A
- Industry
- ACCO Publishing
- ARCT Biotechnology: Pharmaceutical Preparations
- Sector
- ACCO Consumer Discretionary
- ARCT Health Care
- Exchange
- ACCO Nasdaq
- ARCT Nasdaq
- Market Cap
- ACCO 311.7M
- ARCT 298.3M
- IPO Year
- ACCO N/A
- ARCT N/A
- Fundamental
- Price
- ACCO $3.84
- ARCT $13.78
- Analyst Decision
- ACCO Buy
- ARCT Strong Buy
- Analyst Count
- ACCO 1
- ARCT 8
- Target Price
- ACCO $6.00
- ARCT $52.83
- AVG Volume (30 Days)
- ACCO 817.5K
- ARCT 474.9K
- Earning Date
- ACCO 07-31-2025
- ARCT 08-04-2025
- Dividend Yield
- ACCO 7.71%
- ARCT N/A
- EPS Growth
- ACCO N/A
- ARCT N/A
- EPS
- ACCO N/A
- ARCT N/A
- Revenue
- ACCO $1,624,700,000.00
- ARCT $143,680,000.00
- Revenue This Year
- ACCO N/A
- ARCT N/A
- Revenue Next Year
- ACCO $0.58
- ARCT $34.79
- P/E Ratio
- ACCO N/A
- ARCT N/A
- Revenue Growth
- ACCO N/A
- ARCT 15.38
- 52 Week Low
- ACCO $3.32
- ARCT $8.04
- 52 Week High
- ACCO $6.44
- ARCT $25.88
- Technical
- Relative Strength Index (RSI)
- ACCO 56.90
- ARCT 54.34
- Support Level
- ACCO $3.82
- ARCT $13.10
- Resistance Level
- ACCO $4.03
- ARCT $15.20
- Average True Range (ATR)
- ACCO 0.12
- ARCT 1.02
- MACD
- ACCO 0.04
- ARCT 0.07
- Stochastic Oscillator
- ACCO 71.83
- ARCT 55.21
About ACCO Acco Brands Corporation
ACCO Brands Corp designs, manufactures, and markets consumer and business products. It operates through two segments: ACCO Brands Americas, and ACCO Brands International. The company offers school notebooks, janitorial supplies, and whiteboards; storage and organization products, sheet protectors, and indexes, and punching products; computer accessories and others used in schools, homes, and businesses. The company markets and sells its products through various channels, including mass retailers; e-tailers; discount, and variety chains; and warehouse clubs. It generates maximum profit from ACCO Brands America segment.
About ARCT Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in one business segment, which includes all activities related to the discovery, development and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU, and LUNAR-COV19.